Microwave Ablation (MWA) for the Treatment of a Solitary, Chemorefractory Testicular Cancer Liver Metastasis

[1]  M. Gonen,et al.  Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases. , 2014, Journal of vascular and interventional radiology : JVIR.

[2]  S. Nehmeh,et al.  Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. , 2013, Radiology.

[3]  Karen T. Brown,et al.  Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases , 2013, CardioVascular and Interventional Radiology.

[4]  Luigi Solbiati,et al.  Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. , 2012, Radiology.

[5]  L. Solbiati,et al.  Complications of Microwave Ablation for Liver Tumors: Results of a Multicenter Study , 2012, CardioVascular and Interventional Radiology.

[6]  L. Brody,et al.  Superselective Internal Radiation With Yttrium-90 Microspheres in the Management of a Chemorefractory Testicular Liver Metastasis , 2012, CardioVascular and Interventional Radiology.

[7]  T. Powles,et al.  Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Gonen,et al.  CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. , 2011, Journal of vascular and interventional radiology : JVIR.

[9]  M. Bains,et al.  TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  I. Kamel,et al.  Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. , 2009, Journal of vascular and interventional radiology : JVIR.

[11]  R. Motzer,et al.  Medical treatment of advanced testicular cancer. , 2008, JAMA.

[12]  K. Brown,et al.  Treatment of metastatic sarcoma to the liver with bland embolization , 2006, Cancer.

[13]  F. Lee,et al.  Radiofrequency versus microwave ablation in a hepatic porcine model. , 2005, Radiology.

[14]  J. Richie.  Differences in Testis Cancer Survival by Race and Ethnicity: A Population-Based Study, 1973–1999 (United States) , 2005 .

[15]  S. Fosså,et al.  Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Schwartz,et al.  Differences in Testis Cancer Survival by Race and Ethnicity: A Population-Based Study, 1973–1999 (United States) , 2004, Cancer Causes & Control.

[17]  L. Lladó,et al.  Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection , 2003, Cancer.

[18]  B. Leibovich,et al.  Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? , 2003, The Journal of urology.

[19]  A. Horwich,et al.  Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Einhorn,et al.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997. , 2002, The Journal of urology.

[21]  T. de Baère,et al.  Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. , 2000, AJR. American journal of roentgenology.

[22]  K. Brown,et al.  Particle embolization for hepatocellular carcinoma. , 1998, Journal of vascular and interventional radiology : JVIR.

[23]  R. Sylvester,et al.  Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. , 1995, British Journal of Cancer.

[24]  T. Ahlering,et al.  Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. , 1994, Urology.

[25]  L. Einhorn,et al.  Hepatic Resection for Disseminated Germ Cell Carcinoma , 1990, Annals of surgery.

[26]  L. Einhorn,et al.  Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. , 1987, The New England journal of medicine.

[27]  L. Einhorn.  Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. , 1981, Cancer research.

[28]  L. Einhorn,et al.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. , 1977, Annals of internal medicine.